Rhumbline Advisers Tenaya Therapeutics, Inc. Transaction History
Rhumbline Advisers
- $104 Billion
- Q1 2025
A detailed history of Rhumbline Advisers transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 69,193 shares of TNYA stock, worth $33,904. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,193
Previous 80,686
14.24%
Holding current value
$33,904
Previous $115,000
61.74%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding TNYA
# of Institutions
89Shares Held
43.7MCall Options Held
74.3KPut Options Held
192K-
Column Group LLC San Francisco, CA9.4MShares$4.61 Million24.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$3.3 Million0.83% of portfolio
-
Jpmorgan Chase & CO New York, NY5.16MShares$2.53 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$1.6 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $20.3M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...